An all-new interview with Scott Sand, CEO of Ingen Technologies, Inc. is also available on WallSt.net NEW YORK, Feb. 12 /PRNewswire/ -- The Analyst's Review is a daily podcast hosted by WallSt.net editor, Henry Truc that airs every morning at 9 a.m. EST on http://radio.wallst.net/profile.asp?id=193. The show features informative interviews with Wall Street analysts on a wide range of topics including actively traded stocks, market movers, various industries, and macro economic trends affecting the market. On today's show, Doug Chow, analyst for Caris & Company discussed: Genentech, Inc. (NYSE: DNA; http://www.gene.com/) Visit the company's message board at http://www.mywallst.net/forum/viewtopic.php?t=365 Celgene Corp. (Nasdaq: CELG; http://www.celgene.com/) Visit the company's message board at http://www.mywallst.net/forum/viewtopic.php?t=368 Gilead Sciences, Inc. (Nasdaq: GILD; http://www.gilead.com/) Visit the company's message board at http://www.mywallst.net/forum/viewtopic.php?p=928 Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY; http://www.alnylam.com/) Visit the company's message board at http://www.mywallst.net/forum/viewtopic.php?p=929 Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN; http://www.regn.com/) Visit the company's message board at http://www.mywallst.net/forum/viewtopic.php?p=930 "Regarding the sector, I'm very optimistic on 2008," Chow said. "Given the credit issues, and the potential fallout from that, there's increasing market risk on the overall equity market, and biotech, I think is one of the sectors that's more defensive, and one of the sectors that's less likely to be impacted economically." Hear what Chow had to say about today's featured stocks by visiting http://radio.wallst.net/. Click on "The Analyst's Review - Stocks in Focus: DNA, CELG, GILD, ALNY, REGN" to hear the podcast in its entirety. A February 12 interview with Scott Sand, CEO of Ingen Technologies, Inc. (Pink Sheets: IGTG) is also available now at http://www.wallst.net/. Ingen Technologies is a new medical device manufacturer that owns proprietary intellectual property for the growing respiratory market. Interview highlights include detailed discussions on the following topics: -- The company's worldwide distribution partners and distribution strategy -- Reasons the company has been able to enter new markets including China, Japan, Taiwan and Korea -- Target markets, and global market opportunity for the company's medical devices -- Reasons the company's technology improves on current standards -- Upcoming milestones for investors to watch for To hear the interview in its entirety, and to read an in-depth report on the company, visit http://www.wallst.net/superstocks/superstocks_profile.asp?ticker=IGTG Visit the company's message board at: http://www.mywallst.net/forum/viewtopic.php?t=452 About WallStRadio WallStRadio (http://radio.wallst.net/) is owned and operated by WallStreet Direct, Inc., a wholly-owned subsidiary of Financial Media Group, Inc. (http://www.financialmediagroupinc.com/). The Web site offers free access to original content, and more than 150 business and finance podcasts from well- known business news personalities and organizations. WallStreet Direct, Inc. also owns and operates WallSt.net (http://www.wallst.net/), a leading provider of timely business news, executive interviews, multimedia content, and research tools. Financial Media Group, Inc. also owns http://www.mywallst.net/, a financial social network for investors, and Financial Filings Corp. (http://www.financialfilings.com/), a provider of media and compliance solutions to publicly traded companies. The investment professional featured in this podcast and/or their firm may own securities in the companies mentioned in this podcast. We have received two million five hundred thousand restricted shares of IGTG from Ingen Technologies, Inc. for media and advertising services. To read our full disclaimer, and for a complete list of our advertisers, and advertising relationships, visit http://www.wallst.net/disclaimer/disclaimer.asp Contact: Henry Truc WallStRadio 1-800-4-WallSt DATASOURCE: WallStreet Direct, Inc. CONTACT: Henry Truc of WallStRadio, 1-800-4-WallSt

Copyright